FDA Approves Alvotech’s New Simlandi Manufacturing Process
Alvotech said the FDA approved a new manufacturing process for Simlandi, its biosimilar to Humira. Shares rose 8% to $5.41 in morning trading.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.